203 related articles for article (PubMed ID: 22726438)
1. Inhibition of basal FGF receptor signaling by dimeric Grb2.
Lin CC; Melo FA; Ghosh R; Suen KM; Stagg LJ; Kirkpatrick J; Arold ST; Ahmed Z; Ladbury JE
Cell; 2012 Jun; 149(7):1514-24. PubMed ID: 22726438
[TBL] [Abstract][Full Text] [Related]
2. Grb2 controls phosphorylation of FGFR2 by inhibiting receptor kinase and Shp2 phosphatase activity.
Ahmed Z; Lin CC; Suen KM; Melo FA; Levitt JA; Suhling K; Ladbury JE
J Cell Biol; 2013 Feb; 200(4):493-504. PubMed ID: 23420874
[TBL] [Abstract][Full Text] [Related]
3. Direct binding of Grb2 SH3 domain to FGFR2 regulates SHP2 function.
Ahmed Z; George R; Lin CC; Suen KM; Levitt JA; Suhling K; Ladbury JE
Cell Signal; 2010 Jan; 22(1):23-33. PubMed ID: 19735729
[TBL] [Abstract][Full Text] [Related]
4. Composition of receptor tyrosine kinase-mediated lipid micro-domains controlled by adaptor protein interaction.
Rohwedder A; Knipp S; Roberts LD; Ladbury JE
Sci Rep; 2021 Mar; 11(1):6160. PubMed ID: 33731760
[TBL] [Abstract][Full Text] [Related]
5. Competition between Grb2 and Plcγ1 for FGFR2 regulates basal phospholipase activity and invasion.
Timsah Z; Ahmed Z; Lin CC; Melo FA; Stagg LJ; Leonard PG; Jeyabal P; Berrout J; O'Neil RG; Bogdanov M; Ladbury JE
Nat Struct Mol Biol; 2014 Feb; 21(2):180-8. PubMed ID: 24440983
[TBL] [Abstract][Full Text] [Related]
6. Grb2 monomer-dimer equilibrium determines normal versus oncogenic function.
Ahmed Z; Timsah Z; Suen KM; Cook NP; Lee GR; Lin CC; Gagea M; Marti AA; Ladbury JE
Nat Commun; 2015 Jun; 6():7354. PubMed ID: 26103942
[TBL] [Abstract][Full Text] [Related]
7. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
8. Grb2, a double-edged sword of receptor tyrosine kinase signaling.
Belov AA; Mohammadi M
Sci Signal; 2012 Nov; 5(249):pe49. PubMed ID: 23131845
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
Wang X; Weng LP; Yu Q
Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
Li S; Couvillon AD; Brasher BB; Van Etten RA
EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
[TBL] [Abstract][Full Text] [Related]
11. Sprouty2 binds Grb2 at two different proline-rich regions, and the mechanism of ERK inhibition is independent of this interaction.
Martínez N; García-Domínguez CA; Domingo B; Oliva JL; Zarich N; Sánchez A; Gutiérrez-Eisman S; Llopis J; Rojas JM
Cell Signal; 2007 Nov; 19(11):2277-85. PubMed ID: 17689925
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling.
Mood K; Saucier C; Ishimura A; Bong YS; Lee HS; Park M; Daar IO
J Cell Physiol; 2006 Apr; 207(1):271-85. PubMed ID: 16331688
[TBL] [Abstract][Full Text] [Related]
13. Grb2 mediates semaphorin-4D-dependent RhoA inactivation.
Sun T; Krishnan R; Swiercz JM
J Cell Sci; 2012 Aug; 125(Pt 15):3557-67. PubMed ID: 22505611
[TBL] [Abstract][Full Text] [Related]
14. Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells.
Curto M; Frankel P; Carrero A; Foster DA
Biochem Biophys Res Commun; 1998 Feb; 243(2):555-60. PubMed ID: 9480847
[TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor: effects on matrix remodeling, receptor expression, and transduction pathway in human periosteal fibroblasts with FGFR2 gene mutation.
Bodo M; Lilli C; Aisa MC; Scapoli L; Bellucci C; Rinaldi E; Tosi L; Baroni T; Conte C; Bellocchio S; Carinci F; Stabellini G; Carinci P
J Interferon Cytokine Res; 2002 Jun; 22(6):621-30. PubMed ID: 12162872
[TBL] [Abstract][Full Text] [Related]
16. Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases.
Honma M; Higuchi O; Shirakata M; Yasuda T; Shibuya H; Iemura S; Natsume T; Yamanashi Y
Genes Cells; 2006 Feb; 11(2):143-51. PubMed ID: 16436051
[TBL] [Abstract][Full Text] [Related]
17. Grb2 mediates negative regulation of stem cell factor receptor/c-Kit signaling by recruitment of Cbl.
Sun J; Pedersen M; Bengtsson S; Rönnstrand L
Exp Cell Res; 2007 Nov; 313(18):3935-42. PubMed ID: 17904548
[TBL] [Abstract][Full Text] [Related]
18. c-ABL modulates MAP kinases activation downstream of VEGFR-2 signaling by direct phosphorylation of the adaptor proteins GRB2 and NCK1.
Anselmi F; Orlandini M; Rocchigiani M; De Clemente C; Salameh A; Lentucci C; Oliviero S; Galvagni F
Angiogenesis; 2012 Jun; 15(2):187-97. PubMed ID: 22327338
[TBL] [Abstract][Full Text] [Related]
19. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
Saucier C; Papavasiliou V; Palazzo A; Naujokas MA; Kremer R; Park M
Oncogene; 2002 Mar; 21(12):1800-11. PubMed ID: 11896612
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM
Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
